Zydus Lifesciences informs about transcript of earnings call

23 May 2024 Evaluate

Pursuant to regulations 30 and 46(2) (oa) of the Listing Regulations, Zydus Lifesciences has informed that it attached the transcript of the Company’s Q4 FY24 post results earnings call held on May 17, 2024.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

912.90 -1.75 (-0.19%)
01-Jan-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.95
Dr. Reddys Lab 1249.95
Cipla 1499.90
Zydus Lifesciences 912.90
Lupin 2099.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×